Frontage Labs, a US-China CRO, Acquires Biostatistics Firm BDM

Frontage Labs, a US-China CRO majority owned by Hangzhou Tigermed, acquired BDM Consulting of Summerset, N.J., a biostatistics firm. The price was not disclosed. Tigermed already owned a 55% interest in BDM; so Frontage's purchase of a 45% stake gives it and Tigermed exclusive co-ownership. Frontage offers pre-clinical and clinical CRO services in the US and China, while Tigermed is a China clinical-stage CRO. More details.... Stock Symbol: (SHE: 300347) Share this with colleagues: // //